Discover 861 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 861
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Orlando FL, Kissimmee FL, Miami FL, Palmetto Bay FL,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Sex: All
Age: 18 - 70+
Code: NCT06226883
Phase2, Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for
Crohn's Disease
Location: Orlando FL, Kissimmee FL, Tampa FL, Dothan AL,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06045754
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis, Ulcerative Colitis Chronic
Location: Orlando FL, Tampa FL, Miami FL, Chapel Hill NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06598943
Phase2, Recruiting
Circulating Tumor DNA Exposure in Peripheral Blood
Location: Orlando FL, Jacksonville FL, Fort Myers FL,
Sponsor: Proton Collaborative Group
Sex: All
Age: 0+
Code: NCT01255748
Recruiting
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
for
Unresectable Melanoma, Metastatic Melanoma,
Location: Orlando FL, Tampa FL, Miami FL, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT05361174
Phase1, Phase2, Recruiting
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Location: Orlando FL, Tampa FL, Miami FL, Washington D.C. DC,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05208047
Phase3, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Orlando FL, Hollywood FL, Augusta GA, Columbia SC,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase3, Recruiting
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
for
Small Cell Lung Cancer
Location: Orlando FL, Grand Rapids MI, Omaha NE
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07778316
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Orlando FL, Ocoee FL, Wesley Chapel FL, Tampa FL,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase3, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma